Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): Blood urea nitrogen (BUN) and bilirubin

Bone Marrow Transplantation

Volumn 24, Issue 6, 1999, Pages 653-659

  Bacigalupo, A ^a   Oneto, R ^a   Bruno, B ^a   Soracco, M ^a   Lamparelli, T ^a   Gualandi, F ^a   Occhini, D ^a   Raiola, A M ^a   Mordini, N ^a   Berisso, G ^a   Bregante, S ^a   Dini, G ^b   Lombardi, A ^a   Van Lint, M T ^a   Brand, R ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Ospedale San Martino ^*

Author keywords

Bone marrow transplants; GVHD; Transplant mortality

Indexed keywords

BILIRUBIN; HLA ANTIGEN; UREA;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PRIORITY JOURNAL; RISK; UREA NITROGEN BLOOD LEVEL;

EID: 0032855629     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701953     Document Type: Article

References (18)

1. Weiner RS, Bortin MM, Gale RP et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168-175.
2. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-vs-host disease. Br J Haematol 1987; 67: 397-406.
3. Weisdorf D, Hakke R, Blazar B et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197-1203.
4. Storb R, Prentice RL, Thomas ED et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 1983; 55: 573-585.
5. Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729-1736.
6. Nurnberger W, Willers R, Burdach S, Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997; 74: 221-224.
7. Kami M, Mon S, Tanikawa S et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplant 1997; 20: 397-402.
8. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801-808.
9. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153-166.
10. Gaziev D, Polchi P, Galimberti M et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation 1997; 63: 854-860.
11. Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17: 13-18.
12. Kalhs P, Brugger S, Schwarzinger I et al. Microangiopathy following allogeneic marrow transplantation. Transplantation 1995; 60: 949-957.
13. Holer E, Kolb HJ, Hiller E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018-2024.
14. Hill GR, Crawford JM, Cooke KR et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213.
15. Lamparelli T, van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Bone Marrow Transplant 1997; 20: 1057-1062.
16. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-463.
17. Van Lint MT, Uderzo C, Locasciulli A et al. Early treatment of acute graft versus host disease with high or low dose 6-methylprednisolone. A multicenter randomized trial from the Italian group for bone marrow transplantation (GITMO). Blood 1998; 92: 2288-2293.
18. Fink JC, Cooper MA, Burkahrt KM et al. Marked enzymuria after bone marrow transplantation: a correlate of veno occlusive disease induced hepatorenal syndrome. J Am Soc Nephro 1995; 6: 1655-1660.